Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019.

Esther Kissling,Angela Rose,Hanne-Dorthe Emborg,Alin Gherasim,Richard Pebody,Francisco Pozo,Ramona Trebbien,Clara Mazagatos,Heather Whitaker,Marta Valenciano

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin（2019）

Cited 0|Views3

No score

Abstract

Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018-January 2019. Interim results from six studies indicate that 2018/19 influenza vaccine effectiveness (VE) estimates among all ages in primary care was 32-43% against influenza A; higher against A(H1N1)pdm09 and lower against A(H3N2). Among hospitalised older adults, VE estimates were 34-38% against influenza A and slightly lower against A(H1N1)pdm09. Influenza vaccination is of continued benefit during the ongoing 2018/19 influenza season.

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined